Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Unicenter double-masked crossover trial of fluorometholone (FML 0.1%) in dry eye syndrome
2013-002183-63Phase 4Active
- Sponsor
- IOBA
- Start
- Jun 2013
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of fluorometholone in dry eye syndrome (DED) (2 arms), sponsored by IOBA. Primary endpoint: Fluorescein corneal staining. Started Jun 2013; status: active.
02
Drugs
fluorometholone
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on 2013-002183-63.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-002183-63.